Somatic mutation of the tumour suppressor gene TP53 is related to breast cancer subtype, tumour progression, resistance to therapy, and poor prognosis in breast cancer; however, its overall mutation frequency of ~25% is less than expected for a protein that executes key functions that maintain genome integrity [2, 3]. The gene discussed is TP53; the disease is breast carcinoma.